Create a free Feed Strategy account to continue reading

Canada aims to expedite vaccine for African swine fever

In hope of developing an effective vaccine, Canadian researchers will bring African swine fever to their North American laboratories.

Salmonella-Campylobacter-vaccine1
Alwajasm | Freeimages.com

To keep African swine fever (ASF) out of North America, a group of Canadian researchers plans to bring the virus to their home base.

This month, the Canadian Food Inspection Agency (CFIA) cleared the Infectious Disease Organization-International Vaccine Center (VIDO-InterVac) at the University of Saskatchewan to work with African swine fever on-site, making it the first non-government facility in Canada to work with the virus. By increasing the number of laboratories allowed to work directly with the virus, CFIA officials hope to expedite the development of an effective vaccine for the disease — a tool they believe is essential to halting the spread of the virus.

“If we have a vaccine, and can provide that to the countries that have the virus right now, it will minimize the virus in those countries, thereby reducing the possibility of it traveling to other countries,” said Dr. Jaspinder Komal, chief veterinary officer of Canada. Or, if the virus spreads to North America, he said, an effective vaccine would enable officials to contain and eventually eradicate the currently incurable disease.